Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Knowing when and how to realign your budget is crucial for maintaining financial stability. Explore the best practices to ensure timely adjustments.
28,655 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
A viral online persona hid a troubling reality: a calculated scheme built on a bogus cancer crisis. Learn the red fla...
Quantum computing could reshape industries, and early investors may gain. This guide breaks down three stocks to watc...
July markets bring attention to enduring brands and steady income. Coca-Cola's blend of dividend discipline, pricing ...
A Kentucky GOP primary produced a win for a Trump-backed challenger, marking a new chapter in Trump’s hold on the par...
When a high-profile stock takes a sharp fall, the instinct to buy the dip can be strong. This guide breaks down how t...
Beazer Homes stock zooming higher this week has investors buzzing about a potential takeover. This article breaks dow...
AI growth drives data-center electricity demand, creating opportunities for energy players with long-term contracts. ...
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
A public feud over college’s worth heats up in 2026 as Peter Thiel backs alternatives with large grants. The former g...
When the holiday season closed, Ross Stores delivered a clear message: steady demand for its off-price model and a ca...
A new Minneapolis Fed beige book reveals how immigration enforcement pressured hiring, cut ESL enrollments, and tight...